vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and ROGERS CORP (ROG). Click either name above to swap in a different company.
ROGERS CORP is the larger business by last-quarter revenue ($200.5M vs $151.7M, roughly 1.3× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 2.2%, a 5.6% gap on every dollar of revenue. On growth, ROGERS CORP posted the faster year-over-year revenue change (5.2% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $1.1M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -3.3%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
NUTX vs ROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $200.5M |
| Net Profit | $11.8M | $4.5M |
| Gross Margin | 30.4% | 32.2% |
| Operating Margin | 20.4% | — |
| Net Margin | 7.8% | 2.2% |
| Revenue YoY | -41.1% | 5.2% |
| Net Profit YoY | -80.8% | 421.4% |
| EPS (diluted) | $2.34 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $200.5M | ||
| Q4 25 | $151.7M | $201.5M | ||
| Q3 25 | $267.8M | $216.0M | ||
| Q2 25 | $244.0M | $202.8M | ||
| Q1 25 | $211.8M | $190.5M | ||
| Q4 24 | $257.6M | $192.2M | ||
| Q3 24 | $78.8M | $210.3M | ||
| Q2 24 | $76.1M | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $11.8M | $4.6M | ||
| Q3 25 | $55.4M | $8.6M | ||
| Q2 25 | $-17.7M | $-73.6M | ||
| Q1 25 | $21.2M | $-1.4M | ||
| Q4 24 | $61.6M | $-500.0K | ||
| Q3 24 | $-8.8M | $10.7M | ||
| Q2 24 | $-364.0K | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | 30.4% | 31.5% | ||
| Q3 25 | 57.8% | 33.5% | ||
| Q2 25 | 51.2% | 31.6% | ||
| Q1 25 | 55.9% | 29.9% | ||
| Q4 24 | 55.0% | 32.1% | ||
| Q3 24 | 27.8% | 35.2% | ||
| Q2 24 | 29.7% | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | 20.4% | 3.5% | ||
| Q3 25 | 48.7% | 7.3% | ||
| Q2 25 | 13.8% | -33.3% | ||
| Q1 25 | 38.1% | -0.2% | ||
| Q4 24 | 44.4% | -6.6% | ||
| Q3 24 | 12.3% | 6.9% | ||
| Q2 24 | 7.0% | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 7.8% | 2.3% | ||
| Q3 25 | 20.7% | 4.0% | ||
| Q2 25 | -7.3% | -36.3% | ||
| Q1 25 | 10.0% | -0.7% | ||
| Q4 24 | 23.9% | -0.3% | ||
| Q3 24 | -11.2% | 5.1% | ||
| Q2 24 | -0.5% | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | $2.34 | $0.20 | ||
| Q3 25 | $7.76 | $0.48 | ||
| Q2 25 | $-2.95 | $-4.00 | ||
| Q1 25 | $3.33 | $-0.08 | ||
| Q4 24 | $11.56 | $-0.04 | ||
| Q3 24 | $-1.72 | $0.58 | ||
| Q2 24 | $-0.07 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $195.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $1.2B |
| Total Assets | $918.5M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $195.8M | ||
| Q4 25 | $185.6M | $197.0M | ||
| Q3 25 | $166.0M | $167.8M | ||
| Q2 25 | $96.7M | $157.2M | ||
| Q1 25 | $84.7M | $175.6M | ||
| Q4 24 | $40.6M | $159.8M | ||
| Q3 24 | $46.9M | $146.4M | ||
| Q2 24 | $40.8M | $119.9M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $329.4M | $1.2B | ||
| Q3 25 | $317.2M | $1.2B | ||
| Q2 25 | $235.3M | $1.2B | ||
| Q1 25 | $176.9M | $1.3B | ||
| Q4 24 | $132.4M | $1.3B | ||
| Q3 24 | $60.4M | $1.3B | ||
| Q2 24 | $62.7M | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $918.5M | $1.4B | ||
| Q3 25 | $964.5M | $1.4B | ||
| Q2 25 | $841.0M | $1.5B | ||
| Q1 25 | $761.9M | $1.5B | ||
| Q4 24 | $655.3M | $1.5B | ||
| Q3 24 | $438.5M | $1.5B | ||
| Q2 24 | $422.4M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $5.8M |
| Free Cash FlowOCF − Capex | $69.0M | $1.1M |
| FCF MarginFCF / Revenue | 45.5% | 0.5% |
| Capex IntensityCapex / Revenue | 0.9% | 2.3% |
| Cash ConversionOCF / Net Profit | 5.95× | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $70.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.8M | ||
| Q4 25 | $70.4M | $46.9M | ||
| Q3 25 | $99.5M | $28.9M | ||
| Q2 25 | $27.3M | $13.7M | ||
| Q1 25 | $51.0M | $11.7M | ||
| Q4 24 | $54.0K | $33.7M | ||
| Q3 24 | $6.8M | $42.4M | ||
| Q2 24 | $13.3M | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | $69.0M | $42.2M | ||
| Q3 25 | $99.2M | $21.2M | ||
| Q2 25 | $26.5M | $5.6M | ||
| Q1 25 | $50.9M | $2.1M | ||
| Q4 24 | $-341.0K | $18.3M | ||
| Q3 24 | $6.2M | $25.2M | ||
| Q2 24 | $12.7M | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 45.5% | 20.9% | ||
| Q3 25 | 37.0% | 9.8% | ||
| Q2 25 | 10.9% | 2.8% | ||
| Q1 25 | 24.0% | 1.1% | ||
| Q4 24 | -0.1% | 9.5% | ||
| Q3 24 | 7.8% | 12.0% | ||
| Q2 24 | 16.7% | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.9% | 2.3% | ||
| Q3 25 | 0.1% | 3.6% | ||
| Q2 25 | 0.3% | 4.0% | ||
| Q1 25 | 0.0% | 5.0% | ||
| Q4 24 | 0.2% | 8.0% | ||
| Q3 24 | 0.8% | 8.2% | ||
| Q2 24 | 0.7% | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | 5.95× | 10.20× | ||
| Q3 25 | 1.80× | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
ROG
Segment breakdown not available.
